SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-005292
Filing Date
2017-05-15
Accepted
2017-05-15 13:50:37
Documents
50
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 481221
2 ex10-2.htm EX-10.2 38677
3 ex31-1.htm EX-31.1 19176
4 ex31-2.htm EX-31.2 17699
5 ex32-1.htm EX-32.1 6677
6 ex32-2.htm EX-32.2 6821
  Complete submission text file 0001493152-17-005292.txt   2527847

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE prph-20170331.xml EX-101.INS 302859
8 XBRL SCHEMA FILE prph-20170331.xsd EX-101.SCH 36996
9 XBRL CALCULATION FILE prph-20170331_cal.xml EX-101.CAL 52272
10 XBRL DEFINITION FILE prph-20170331_def.xml EX-101.DEF 97131
11 XBRL LABEL FILE prph-20170331_lab.xml EX-101.LAB 249773
12 XBRL PRESENTATION FILE prph-20170331_pre.xml EX-101.PRE 174310
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21617 | Film No.: 17843085
SIC: 2834 Pharmaceutical Preparations